Chronical Pain News
-
Showcase
Improve Your Wellbeing with Remedial Massage in Hobart City: How to Find the Right Therapist
Welcome to the definitive resource to improving your wellbeing with remedial massage in Hobart City! If you want to eliminate stress, ease tension, and improve your overall health, you’ve come to the correct place. In this blog post, we’ll look at the many benefits of remedial massage and offer helpful advice on how to select the right therapist for you. So sit back, relax, and ...
-
Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference
Positive results confirm findings from prior studies evaluating the abuse potential of cebranopadol, further highlighting its potential as a safe and potent alternative to traditional opioids Registrational phase 3 clinical trials of cebranopadol in moderate to severe acute pain are on track to initiate in Q4 2023 – Business Wire – Tris Pharma, Inc. (Tris), a commercial-stage ...
-
Meagan Medical Inc. Announces Issuance of a Key U.S. Patent for a Disruptive Chronic Pain Treatment using Spinal Cord Stimulation
Patent provides protection for High Frequency Spinal Cord Stimulation with Beat Technology Vancouver, Washington – March 20, 2015 – Meagan Medical Inc., a clinical research and medical device development company focused on investigating and developing optimal ways of managing and controlling pain, announced today the issuance of a key patent related to a unique ...
-
Targeting Alternative Opioid Receptor Reduces Drug Side Effects
A new study published in Proceedings of the National Academy of Sciences (PNAS) indicates, “Delta opioid receptors have a built-in mechanism for pain relief and can be precisely targeted with drug-delivering nanoparticles, making them a promising target for treating chronic inammatory pain with fewer side eects.” Researchers used cells from humans and mice with inammatory bowel ...
-
Endosomal Signaling Of Delta Opioid Receptors Is An Endogenous Mechanism And Therapeutic Target For Relief From Inflammatory Pain
Whether G protein-coupled receptors signal from endosomes to control important pathophysiological processes and are therapeutic targets is uncertain. We report that opioids from the inflamed colon activate δ-opioid receptors (DOPr) in endosomes of nociceptors. Biopsy samples of inflamed colonic mucosa from patients and mice with colitis released opioids that activated DOPr on nociceptors to ...
-
1st Patient treated with Vetex Thrombectomy Catheter
Vetex™ Medical Ltd., an innovator in deep vein thrombosis (DVT) treatment, announced it’s first patient on December 18th, 2018, treated in the VETEX (Venous Thrombus Extraction) Study, a first-in-man, multicenter study of the Vetex™ Thrombectomy Catheter. The Vetex device is the first DVT device to combine rotational and grasping action to quickly and gently remove large volumes ...
-
Tris Pharma Reports Positive Topline Data from Clinical Study of Investigational Pain Therapy Cebranopadol Showing Significantly Less Potential for Abuse Versus Tramadol and Oxycodone
Study evaluating human abuse potential demonstrates that the likeability of cebranopadol administered orally in nondependent recreational opioid users was significantly less as compared to immediate release (IR) formulations of either tramadol or oxycodone, suggesting a lower potential for abuse versus traditional C-II and C-IV opioids A first-in-class investigational analgesic uniquely ...
-
Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego
Active Implants, a company that develops orthopedic implant solutions, today announced that the company’s SUN (Safety Using NUsurface) trial is now underway in San Diego. Dr. Scott A. Hacker at Grossmont Orthopaedic Medical Group is the only physician in San Diego County – and the center is one of just 10 sites nationwide – participating in the SUN clinical trial to evaluate the ...
-
Treatment of Prostatitis - What Forms of Medicines Released?
Prostatitis is a disease characterized by the presence of inflammation and/or infection localized in the prostate gland. ...
-
Creative Medical Technology Announces Positive Top-Line Results for StemSpine Pilot Study
Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced positive two-year follow-up data for the Company's StemSpine® pilot study, showing significant efficacy of the StemSpine® ...
-
What to Expect for an Epidural Injection
Roughly 8% of U.S. adults suffer from persistent or chronic back pain. That’s around 65 million people who are prevented from engaging in daily activities. Many are forced to miss days of work due to injury. With rising healthcare costs, many back pain sufferers think that they are left without a real solution, until they try epidural injections. An epidural injection is the infusion of ...
-
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine Study
Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, today announced the peer reviewed publication of positive, two-year follow-up data for the Company's StemSpine® study, showing significant efficacy of ...
-
Flowonix Medical Inc. And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy
Flowonix Medical Inc. of New Jersey, and Colorado-based Cerebral Therapeutics, announced today the first patients implanted with the Prometra II Programmable Infusion System in the Australian Direct Drug Administration for Refractory Epilepsy (ADDRESS) clinical trial at St. Vincent's Hospital, Melbourne, Australia. The jointly developed therapy features a micro-infusion device that tightly ...
-
Robotic innovation delivers relief for back pain sufferers
An innovation that automates the diagnosis and treatment of chronic back pain could bring benefits to millions of patients, increase work productivity and provide therapists with a time-saving ...
By Adamo Robot
-
Physiotherapy for back pain with a contactless AI robot - Spain Adamo Robot
The protocol for the treatment of chronic back pain is difficult to establish, but certain results of physical therapy are expected. A fully automated physical therapy robot has been developed to promote the use of physical therapy and improve the productivity of physical ...
By Adamo Robot
-
The future of precise personalised robotic physiotherapy
Imagine a robot that gives therapeutic massages. The essence of this new medical advance is to improve access to physical therapy for people with chronic back pain. The EU-funded ADAMO Robot project is developing a robotic arm that provides precise therapeutic treatment by applying compressed air to a patient’s back. An artificial intelligence (AI) system can monitor the progress of the ...
By Adamo Robot
-
Landmark Survey by Stagwell`s The Harris Poll Estimates More Than 72.3 Million U.S. Adults Suffer from Chronic Low Back Pain - Greater than Arthritis, Diabetes, or Heart Disease and with Debilitating Impact on Quality of Life
Significant Drop in Mobility Due to Chronic Low Back Pain (CLBP) Demonstrated in New Mobility Index, with Highest Drop Among Those in Their 50s Treatment is Deficient with 15% Currently Taking Opioids Despite CDC Guidelines Noting Inadequate Effectiveness and Inherent Risks Only 5% Utilizing Recommended Minimally Invasive Treatment Options The Harris Poll, a Stagwell (NASDAQ: STGW) ...
-
Aresus announces presentation of clincial data for the treatment of female sexual pain with sinecatechins ointment
Aresus Pharma GmbH, a subsidiary of DERMAGO GmbH, announced today that clinical results on the efficacy of 5-10% Topical Sinecatechins (synonyms: “Polyphenon® E“, ”defined extract from green tea leaves“) Ointment for Postmenopausal Vestibulodynia1 were presented at the 2nd Congress on Women’s Health Innovations & Inventions in Tel Aviv on July 11-12th, 2022. ...
-
Nalu Medical, Inc. Names Thomas West President and Chief Executive Officer
Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced today that the Board of Directors has appointed Thomas “Tom” West as President and Chief Executive Officer. This leadership appointment is effective on August 8th and follows the decision by Earl Fender, Nalu’s current CEO, to ...
-
ZDF Report: CUREO VR Therapy at Long Covid
In an exciting report by ZDF, it is shown how CUREO can be used as a therapy method for Long Covid patients. In addition to acutely affected covid patients, many people struggle with the long-term consequences of the disease. These can be treated efficiently with CUREO. In addition to acutely affected Covid patients, many people also have to struggle with the long-term consequences of the virus. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you